A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

Clinical trial NCT07489482 · RECRUITING

Trial details

NCT number: NCT07489482
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2026-04-02
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.